Studies have focused on the MALT1 paracaspase activity and NF-κB signaling in the immunity of lymphoma, suggesting that dysregulation of this process may result in immune defects, autoimmune diseases, or cancers [18,19,20,21,22]. The gene discussed is NFKB1; the disease is cancer.